"contract orientation and kickoff meeting", task order #1 under 75N91019D00012. Task order period of performance: 1/25/2019-2/24/2019.
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5 Part of Illinois Institute Of Technology
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,399
Award facts
- Opportunity
-
- PREVENT Cancer Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Biomarker Endpoints, Preclinical Services for Biopharmaceutical Product Development and Manufacturing, and Toxicology and Pharmacology Testing Pre-Solicitation · N01CN7701918 · Posted Apr 19, 2018
- PREVENT Cancer Preclinical Drug Development Program Award Notice · Posted May 7, 2018
- Contract value 100% obligated
- $2,398.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Chicago, IL 60616, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$1,101 | |
| Original award | $3,500 |
About this award
This task order was awarded under the PREVENT Preclinical Drug Development Program multiple award contract vehicle by the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services. The task order, valued at approximately $2,400, is for a contract orientation and kickoff meeting to be provided by IIT Research Institute, the prime contractor, located in Chicago, Illinois. The period of performance is January 25, 2019 through February 24, 2019. The PREVENT program supports preclinical efficacy and intermediate biomarker research to facilitate the development of new drugs and therapies for the prevention and treatment of cancer. No set aside designation was specified.
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on January 23, 2019.
How much is contract 75N91019F00129 worth?
The government has obligated $2,399 on 75N91019F00129.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a delivery order under 75N91019D00012, an indefinite delivery contract, on PREVENT Preclinical Drug Development Program (PREVENT).
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was full and open competition. The government received 7 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award